trending Market Intelligence /marketintelligence/en/news-insights/trending/gFZzHc1FSYJBwAiXxze5iQ2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

IRRAS to launch IPO on Nasdaq First North Premier

COVID-19 Pandemic Likely To Cause US Telemedicine Boom

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

IRRAS to launch IPO on Nasdaq First North Premier

IRRAS AB is launching an IPO on Nasdaq First North Premier in Stockholm.

The Stockholm-based medical technology company will issue up to 350 million Swedish kroner in new shares, which will trade under the ticker IRRAS.

The shares will be offered within the price range of 45 kroner to 50 kroner.

Existing shareholders Serendipity Ixora AB (publ) and Vandel Medical Equipment Ltd. have agreed to subscribe for 35 million kroner in shares.

Assuming full subscription of the offering and full exercise of the overallotment option, the offering will amount to 402.5 million kroner.

Trading of IRRAS' shares on Nasdaq First North Premier is expected to commence Nov. 22. The expected settlement date is Nov. 24. Nasdaq Stockholm admitted the shares Nov. 13, subject to certain conditions.

The offering is conditional upon it generating proceeds of at least 260 million kroner after issue expenses.

The company will use proceeds of the float to finance its next phase of commercialization, to expand the platform for its IRRAflow external drainage device system, and to diversify its ownership structure.

ABG Sundal Collier AB serves as the sole global coordinator of the offering. Vator Securities AB acts as the financial adviser.

As of Nov. 13, US$1 was equivalent to 8.39 Swedish kroner.